OUR PRODUCTS ARE NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE
Reported Adverse Effects In the available case series and observational literature, the most commonly reported adverse effects include: Injection-site redness or mild induration in approximately 8 to 12% of users Transient nausea, most often associated with oral formulations or higher injectable doses Lightheadedness in a small number of patients shortly after injection (under 2% of reported cases) Vivid dreams or mild sleep changes, reported anecdotally by a subset of users with no clear mechanistic explanation No published human case reports as of July 2025 document serious organ toxicity, malignancy, or endocrine disruption attributable to BPC-157
Watchful waiting versus elective repair for asymptomatic and minimally symptomatic paraesophageal hernias: A cost-effectiveness analysis
Injury recovery Investigated in animal studies on recovery from soft-tissue injury, including tendon, ligament, and muscle models
At this time, there is no evidence showing that BPC-157 directly: Burns body fat Targets fat cells Increases fat oxidation Suppresses hunger hormones Creates a calorie deficit Heres a simple breakdown: Understanding this difference helps set realistic expectations about BPC-157 and weight loss
Safe and Affordable What are the side effects